Guardant Health Inc (NASDAQ: GH) on Friday, plunged -1.73% from the previous trading day, before settling in for the closing price of $47.28. Within the past 52 weeks, GH’s price has moved between $20.14 and $53.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -33.61% over the past five years. The company achieved an average annual earnings per share of 23.80%. With a float of $117.75 million, this company’s outstanding shares have now reached $123.65 million.
Let’s look at the performance matrix of the company that is accounted for 2021 employees. In terms of profitability, gross margin is 61.34%, operating margin of -58.78%, and the pretax margin is -53.67%.
Guardant Health Inc (GH) Insider Updates
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Guardant Health Inc is 4.95%, while institutional ownership is 96.59%. The most recent insider transaction that took place on Jul 17 ’25, was worth 5,591. In this transaction Director of this company sold 116 shares at a rate of $48.20, taking the stock ownership to the 7,324 shares. Before that another transaction happened on Jul 17 ’25, when Company’s Director sold 26 for $48.20, making the entire transaction worth $1,253. This insider now owns 18,196 shares in total.
Guardant Health Inc (GH) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 23.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.74% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Guardant Health Inc (GH) is currently performing well based on its current performance indicators. A quick ratio of 3.76 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.29 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 1.89 million, a negative change from its year-to-date volume of 2.28 million. As of the previous 9 days, the stock’s Stochastic %D was 6.30%.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 62.46%, which indicates a significant increase from 6.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.83 in the past 14 days, which was lower than the 2.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.99, while its 200-day Moving Average is $39.12. Nevertheless, the first resistance level for the watch stands at $47.60 in the near term. At $48.75, the stock is likely to face the second major resistance level. The third major resistance level sits at $49.52. If the price goes on to break the first support level at $45.68, it is likely to go to the next support level at $44.91. Assuming the price breaks the second support level, the third support level stands at $43.76.
Guardant Health Inc (NASDAQ: GH) Key Stats
Market capitalization of the company is 5.76 billion based on 123,888K outstanding shares. Right now, sales total 739,020 K and income totals -436,370 K. The company made 203,470 K in profit during its latest quarter, and -95,160 K in sales during its previous quarter.
